Purpose Although half of women and one-quarter of men aged 50 and older will sustain an acute low-trauma fracture, less than a quarter receive appropriate secondary fracture prevention. The goal of this quality improvement demonstration project was to implement a Fracture Liaison Service (FLS) focused on secondary prevention of an osteoporotic fracture in three open health care systems aided by a cloud-based tool. Methods The pre-post study design examined the proportion of men and women over age 50 who received appropriate assessment (bone mineral density, vitamin D levels) and treatment (calcium/vitamin D, pharmacologic therapy) in the six months following a recently diagnosed fracture. The pre-study (Pre FLS) included a retrospective chart review for baseline data (N = 344 patients) within each health care system. In the post-evaluation (Post FLS, N = 148 patients), the FLS coordinator from each health care system examined these parameters following enrollment and for 6 months following the recently diagnosed fracture. Data were managed in the cloud-based FLS application tool. Results Ninety-three participants completed the program. The FLS program increased the percentage of patients receiving bone mineral density testing from 21% at baseline to 93% (p < 0.001) Post FLS implementation. Assessments of vitamin D levels increased from 25 to 84% (p < 0.001). Patients prescribed calcium/vitamin D increased from 36% at baseline to 93% (p < 0.001) and those prescribed pharmacologic treatment for osteoporosis increased on average from 20 to 54% (p < 0.001) Post FLS. Conclusions We conclude that the FLS model of care in an open health care system, assisted by a cloud-based tool, significantly improved assessment and/or treatment of patients with a recently diagnosed osteoporotic fracture. Future studies are necessary to determine if this model of care is scalable and if such programs result in prevention of fractures. Mini-Abstract: The goal was to implement a Fracture Liaison Service (FLS) focused on secondary prevention of an osteoporotic fracture in open health care systems aided by a cloud-based tool. This model significantly improved assessment and/or treatment of patients with a recently diagnosed fracture.
Introduction
One of two women and one of four men over age 50 will sustain an osteoporotic fracture in their lifetime [1] with a current estimated annual cost of $14 to $20 billion [2] . Hip and vertebral fractures both have a mortality of roughly 20% in the 5 years following the acute event [3] . Furthermore, a low-trauma fracture predicts a greater than twofold increased risk of a future fracture [4] [5] [6] [7] with an annual cost of over $1 billion in the United States for the second fracture [8] . Despite these statistics, only about 21% of osteoporotic fractures are identified or treated in the United States [9] .
TheFractureLiaisonService(FLS)modelofcarehasimproved treatment for osteoporotic patients and prevented secondary fractures [10] [11, 12] . The FLS model connects bone health specialists with the patient's primary care physician and employs a coordinator (nurse practitioner, physician assistant, registered nurse, or other health care professional) to ensure patients are appropriately diagnosed, treated, and followed [10, 13] . In the United States, the FLS model has been used primarily in Bclosed^health care systems in which the payer, hospital, patient, and physicians are closely aligned. For example, the FLS model developed at Kaiser Permanente Southern California employs the services of a FLS coordinator who can readily identify the patient with a recently diagnosed fracture,orderbone density testing,andbegintherapy with the cooperation of the primary care physician [14] . This FLS model has resulted in a 40% reduction in hip fractures [14] . Similar results have also been demonstrated at the Geisinger Health System in Pennsylvania (which also has a closely aligned system of health care) [15] and within health care systems outside of the United States [16] [17] [18] [11, 12] . This type of post-care implementation has been difficult in Bopen^systems in the United States, in which the payers, hospitals, health systems, and patients are often independent, have minimal alliance or open communication, and are often in a state of change. Cosman and colleagues improved non-pharmacologic measures with an FLS, but not the use of osteoporosis medications for patients 4-6 months after hip fracture in an open system [19] . Additionally, there is often minimal connectivity between the electronic records of the hospital system and the primary care physician or clinic, making follow-up difficult. Therefore, the goal of this demonstration project was to determine if secondary prevention of a recently diagnosed fracture could be initiated in an open model of care within three independent health care systems aided by a fracture liaison team and coordinated utilizing a cloud-based tool to track patients. Furthermore, we aimed to examine the barriers and challenges to this model, develop workable solutions for each system, and implement successful strategies to improve outcomes.
Methods

Study design
The study design was a pre-post comparison of fracture care before and after implementation of the FLS program at three facilities (sites A, B, and C).
Pre/baseline retrospective assessment (Pre FLS)
The baseline assessment included a retrospective chart review to obtain data on the number of adults who received bone mineral density studies, vitamin D testing, calcium/vitamin D supplementation, and appropriate osteoporosis therapy within six months following a recently diagnosed acute lowtrauma fracture.
The post FLS prospective assessment (Post FLS)
The FLS comparison included a prospective study of patients identified with an acute low-trauma fracture followed over six months for the same outcomes assessed above, but with the aid of the FLS model of care and the cloud-based tool. Patients were enrolled between April and December 2014 and followed through June 2015 to allow six-month follow-up for all participants. All participants were counseled on appropriate lifestyle behaviors to prevent secondary fractures as suggested by National Osteoporosis Foundation (NOF) guidelines [20] .
FLS team and coordinators
Site A serves over 500 patients each year with low-trauma fractures. The FLS team consisted of a physician champion who performed the majority of follow-up, assisted by research and nurse coordinators. There are currently separate inpatient and outpatient electronic health record systems. Site B serves over 600 older adults with low-trauma fractures each year. There are separate inpatient and outpatient electronic health record systems. The FLS team consisted of a physician champion and the nurse practitioner who was the primary coordinator of patient care and follow-up. Site C serves roughly 450 patients with low-trauma fractures each year. The team consisted of a physician champion and an orthopedic nurse who was responsible for identification and follow-up. In addition to a change in the major insurance carrier, the outpatient and inpatient medical health records at site C changed from paper files to electronic medical records during the course of the study.
Participants
Men and women 50 years of age and older with a recently diagnosed fracture were identified by the FLS coordinators through the orthopedic clinic, neurosurgery clinic, emergency department, hospital admissions, other referrals, and word of mouth. Patients were excluded if they had sustained a traumatic fracture, had a cancer-related fracture, or were currently on osteoporosis therapy. Patients were enrolled as part of a quality improvement program. After review by the Johns Hopkins University IRB, each facility had an independent review and/or received approval by their Quality Improvement committee.
Outcomes
The primary outcomes included the proportion of participants who received (1) a bone mineral density (BMD) test by dual x-ray absorptiometry (DXA), (2) serum vitamin D level assessment, (3) calcium/vitamin D supplementation, and (4) appropriate pharmacologic therapy for osteoporosis.
Pharmacologic therapies included FDA-approved bisphosphonates, selective estrogen receptor modulators (SERMs), calcitonin, denosumab, and teriparatide [20] . Not all patients were deemed eligible for osteoporosis therapy. For example, a patient may have sustained a low-trauma fracture, but based on factors such as fracture type, clinical risk factors, or low Fracture Risk Assessment Tool (FRAX) risk of future fracture [20] , it may have been determined that he/she did not require pharmacologic therapy at the current time. This was Bappropriate^treatment based on the NOF and FRAX guidelines and clinical assessments [20, 21] and indeed, the patient would still have received evaluation and counseling on calcium/vitamin D and lifestyle behaviors for fracture prevention. Fracture site was identified by ICD-9 code.
Implementation, barriers, and challenges
We examined implementation, barriers, and challenges encountered by the three sites during the demonstration project and explored potential solutions for each local facility (Table 1) . For example, the FLS teams and champions were led primarily by a physician at one site, a nurse practitioner at a second site, and by an orthopedic nurse coupled with a physician at a third site. Patients were identified by a variety of methods including through the orthopedic or trauma service, by referral to the FLS, through the emergency department and via radiology reports that demonstrated a recently diagnosed fracture. Follow-up also occurred through many routes, including coupling with the orthopedic follow-up visit (often occurring approximately 2 weeks after the acute event), referral to a specialty clinic, referral to the FLS physician champion, and teleconferencing directly with the patient. The primary care provider for the patient received communication by many routes including a direct teleconference, letters, or through the electronic health record. Notifications to the primary care provider included the results of the bone mineral density (DXA) report and laboratory testing as well as the FLS program recommendations. The three sites often used multiple solutions, learned from each other, and found that the best solutions depended on the local environment and circumstances.
The MedConcert FLS application
The MedConcert FLS application (FLS App) was developed for the Fracture Liaison Service Model of Care Demonstration Project in the MedConcert cloud-based platform. Details of the application's development, functionality, and role of stakeholders have been previously described [22] . The FLS demonstration project was a collaborative effort among CECity. com, Inc.®, a subsidiary of Premier, Inc., the technology partner, the National Bone Health Alliance (NBHA), NOF, and the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. The MedConcert application had been designed to help collect data for seven quality-of-care measures including those from the National Quality Forum, the Joint Commission, and the Centers for Medicare and Medicaid Services. Briefly, the FLS App included a five- step approach (identify, inform, initiate, investigate, and iterate) to help organize the post-fracture care follow-up and tasks within a reasonable timeline. The FLS App was independent from the electronic health record systems of the facilities.
Data collection
Baseline data Pre FLS were collected retrospectively from the patient's health records from each site. Post FLS fracture patients were identified and their medical records were reviewed to assess outcomes during the six-month period following the fracture using a standardized form. In addition to demographic information, the major outcomes of interest were extracted from the records. The prospective data were collected utilizing the FLS application tool.
Analysis
We used a pre-post design to evaluate the effectiveness of the program. To assess the impact of the demonstration project, we compared the same outcomes of interest in patients from the retrospective baseline analysis Pre FLS to patients in the prospective study Post FLS who were prescribed these outcomes in six months or less following enrollment at each of the three sites (sites A, B, and C). Descriptive data are reported, including mean, standard deviation (SD), standard error (SE), and percentages. Wilcoxon rank sum tests were used to examine differences in continuous variables and chi-square tests or Fisher's exact tests were used to examine differences for categorical variables. Analysis was completed with STATA version 13.1 (STATA Corporation, College Station, Texas). P value less than 0.05 was used to determine statistical significance.
Results
Pre FLS analysis
Three hundred forty-four men and women over age 50 were included in the retrospective analysis ( Table 2 ). The mean age (± SD) was 71 ± 12 years and included 19% men and 81% women. At baseline, 21.3% (range 12.7-26.6% across the three sites) had a bone mineral density test and 19.5% (range 5-42.3%) received pharmacologic medication in the six months post-fracture (Table 2) .
Post FLS analysis
One hundred forty-eight patients were identified and 93 completed the six months of follow-up. Fifty-five patients not completing the follow-up were excluded from the analysis and included 19 who were lost to follow-up, 16 patients or 23 (14) 34 (34) 16 (7) 33 (48) 27 (12) 29 (101) 22 ( 18 (11) 4 (4) 0 (0) 3 (5) 24 (11) 4 (14) 15 (22) a P values only include those in which the race was recorded b
Because of round-off errors, column does not add up to 100%
family members who refused participation, eight who preferred to be followed by their primary care physician, five who felt the geographic location or distance was a barrier, and seven who had miscellaneous reasons. There were no significant differences in the age, gender, race, or types of fracture between those who completed the follow-up and those who did not. The fracture sites are shown in Table 3 . The patient's age, gender, and race were similar between baseline and post-pilot in all three sites, except that more female patients were identified in the post-pilot at site B compared to its baseline patients (66% Pre FLS and 84% Post FLS, Table 2 ).
Effect of the demonstration project: Pre-Post FLS comparison
The percentage of patients receiving bone mineral density testing significantly increased from 21.2 ± 2.5% (mean ± SE) Pre FLS to 92.9 ± 2.7% Post FLS (p < 0.001) (Fig. 1) . Vitamin D measurements increased from 25.2 ± 2.5% at baseline to 84.0 ± 3.8% with the FLS service (p < 0.001). Patients prescribed vitamin D or calcium significantly increased from 35.8 ± 2.8% to 92.6 ± 2.2% and patients prescribed pharmacologic treatment for osteoporosis increased from 19.5 ± 2.6% to 54.1 ± 5.8% (both p < 0.001) Post FLS.
Sites A and B improved all of the outcomes for postfracture treatment (Table 4) . For site C, bone mineral density testing and vitamin D/calcium prescribing improved significantly following the FLS service. Vitamin D measurements were unchanged before and after the FLS service. Due to a change in insurance carriers, site C was not able to prescribe pharmacologic therapy (Table 4) . Specifically, pharmacologic prescriptions decreased from 42.3% to 16.7% (p = 0.045). In comparison, pharmacologic prescriptions increased from 16.4% to 57.6% at site A (p < 0.001) and from 5.0% to 78.3% at site B (p < 0.001).
Discussion
Secondary fracture prevention is a critical component of osteoporosis care, but less than a quarter of patients with an acute osteoporotic (low-trauma) fracture are identified and treated in the United States [1, 9] . Computer-generated simulation models have demonstrated that an FLS program is costeffective for a health care system [13, 23] [24] . Despite a growing body of evidence demonstrating the benefits of the FLS model in closed systems in both the United States with a single payer and provider [14, 15] and abroad with very different models of government provided care [16] [17] [18] , most U.S. hospitals or health care systems have not adopted this model. In this demonstration project, we observed significant improvement in diagnostic testing and treatment in three large health systems with open models of care that utilized an FLS team/champion and a cloud-based tool to facilitate postfracture management. Each team encountered local barriers and challenges that were successfully addressed with innovative solutions in many but not all cases.
There were multiple challenges that were encountered throughout the study that resulted in some innovative solutions described in Table 1 . These barriers were often local, time sensitive, and evolved with changes in the health care environment or payer system available to our patients [25] . The overall goal was to provide appropriate post-fracture care, and the FLS team worked within their local constraints to overcome obstacles. They were not always successful, as demonstrated by the decrease in use of osteoporotic medications at site C when the payer system changed. It is important to highlight these barriers and consider alternatives to manage such hurdles that are likely to emerge with ongoing health care reform and government regulations.
Physicians, payers, and health care systems are currently being evaluated for quality metrics including the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) measure that examines if post-fracture patients age 65-85 receive a DXA/ bone mineral density scan and/or osteoporosis medication within six months after an acute osteoporotic fracture [26] . The HEDIS and other quality measures (Table 1) will impact incentives and penalties for the payer, hospital, health care system, or physician/group that participate in the Medicare Advantage Five Star program [27] . For example, prior to the FLS program, the HEDIS post-fracture measure performance rates for two of the demonstration sites were roughly in a range equivalent to a one star category (two stars requires obtaining at least 34% of the benchmark). Following initiation of the FLS model of care and use of the MedConcert FLS App, the five star HEDIS performance metric was achieved by all three sites for the patients prescribed a DXA and/or pharmacologic therapy. This demonstration project did have limitations. First, as in many pilot studies, the sample size was small, which reduces the chances of being able to detect small effects of the intervention statistically. Moreover, the findings may not be applicable to other hospitals or health care systems. Second, the data collection approach differed for baseline and Post-FLS study which may have influenced or biased the results. For the baseline assessment, the Bdata not captured^could have occurred if the test was not done, not recorded, or recorded elsewhere. This is exemplified by the Pre FLS variability in the Bdata not captured^among the three sites. Post FLS, the MedConcert FLS application eliminated this unknown and provided a standardized approach to capture the data. Third, because of the short time frame in which the pilot project was conducted, it was not possible to demonstrate a reduction in secondary fractures. The follow-up time was only six months, with the goal to assess participants receiving a DXA, vitamin D measurements, calcium/vitamin D supplementation, or osteoporosis therapy. The ultimate goal will be to determine the number of fractures that are prevented, but larger and longer studies are needed to establish this clinical benefit. Fourth, although the number of participants who completed six months of follow-up was 63%, this was a pragmatic and quality improvement program in a changing health care environment. Those who did allow the follow-up achieved clinically relevant goals to benefit their skeletal health. Lastly, there is no comparison group for this study, and it is possible that changes over time may be due to secular trends toward improvement. The improvements in specific outcomes are notable (especially in site A and site B), however, which suggests targeted change efforts due to function of the FLS model rather than general trends.
Our project also had several advantages. First, this pilot demonstration project allowed implementation of real-time pragmatic changes in response to the evolving health care environment. Second, procedures were not rigid but rather allowed flexibility to derive the best possible outcomes. Third, rather than a standard FLS team often directed by a physician, we allowed for alternative non-physician champions or practitioners to lead the charge. Fourth, the MedConcert FLS application provided multiple benefits for the FLS coordinator. The application was cloud-based, providing easy access to the database and registry. The FLS coordinator could see all patients at a glance and their current stage of follow-up. The dashboard and alert systems ensured that visits or assessments were not missed. However, future versions will need the FLS application to be integrated with the electronic medical record at the health care system or facility and could have the national quality metrics embedded into the application. Fifth, follow-up for participants was done by a variety of means that depended on the acceptability and climate for each facility. Since this was a quality improvement project, each site was able to develop the best model that worked within each health care system. This demonstration project highlights that FLS care models are variable and dynamic with flexibility that allows for robust and successful outcomes.
In conclusion, the FLS model of care assisted by a cloudbased MedConcert FLS application in three Bopen^health care systems was an effective method to monitor and treat Table 4 Comparison Patients who did not require the test or prescription were not included in the analysis osteoporotic patients post-fracture. Further studies are needed to determine if the tool and care models are scalable. It is essential to determine if these improvements in post-fracture care will ultimately translate into a reduction in secondary fractures.
